HALOZYME THERAPEUTICS, INC. (HALO) Shareholders’ equity 2016–2025
HALOZYME THERAPEUTICS, INC. (HALO) shareholders’ equity at each fiscal year-end, per SEC filings.
$48.8MFY2025 · since FY2016: -$32.5M → $48.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $48.8M | -86.6% |
| FY2024 | $363.8M | +334.1% |
| FY2023 | $83.8M | -50.6% |
| FY2022 | $169.8M | -13.8% |
| FY2021 | $197.0M | +30.4% |
| FY2020 | $151.0M | +64.6% |
| FY2019 | $91.8M | -63.1% |
| FY2018 | $248.9M | +19.4% |
| FY2017 | $208.4M | +741.5% |
| FY2016 | -$32.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice